Thursday, June 24, 2021
- Advertisement -spot_img

TAG

longhaulers

New study probes Covid-19 long-haulers

Regeneron Pharmaceuticals Inc said Tuesday its dual antibody treatment for Covid-19 reduced symptomatic illness by four days at any level of dose tried in its...

Latest news

- Advertisement -spot_img